Hence, combined overexpression of Hoxa9 and Meis1 leads to upregulation of Syk at the post-transcriptional level, and elevated SYK expression is associated with HOXA9/MEIS1 overexpression in human AML samples. This evidence concerns the gene MEIS1 and acute myeloid leukemia.